N.J. Admin. Code § 17:30A-5.2

Current through Register Vol. 57, No. 1, January 6, 2025

Section 17:30A-5.2 - Advisory review panel; membership; responsibilities

(a) The Commission shall appoint an advisory review panel (panel) to make recommendations to the Commission regarding the addition of debilitating medical conditions that should qualify for medicinal marijuana and, upon the Commission's request, to provide guidance and recommendations regarding the medicinal use of marijuana.

1. In response to the Commission's request for its guidance and recommendations, the advisory review panel may examine scientific and medical evidence and research and may gather information, in person or in writing, from persons and entities who are knowledgeable about the medicinal use of marijuana.

(b) The panel shall consist of not more than 15 health care professionals, among whom shall be:

1. The President of the Board of Medical Examiners, or the President's designee;

2. Other physicians and non-physicians who are knowledgeable about the medicinal use of marijuana.

i. Each physician appointed to the review panel shall be nationally board-certified in his or her area of specialty.

ii. At least three physicians appointed to the review panel shall have expertise in pain and symptom management; and

3. Physicians shall comprise the majority of the panel.

N.J. Admin. Code § 17:30A-5.2

Amended by R.2019 d.049, effective 5/20/2019.
See: 50 N.J.R. 1398(a), 51 N.J.R. 732(a).
Section was "Panel to review petitions and make recommendations for identification and approval of additional debilitating medical conditions; membership; responsibilities". Rewrote the section.